Our Research

The focus of our research is developing viral vector-based gene replacement strategies for the treatment of inherited ocular disease.

Female scientist carefully placing liquid into lab equipment Play Video

Meet Dr. Boye

Dr. Shannon E. Boye received her B.S. in marine biology with a minor in chemistry from Fairleigh Dickinson University in 2001. She graduated with a Ph.D. in Neuroscience from the University of Florida in 2006. Her thesis work involved developing viral vectors for the treatment of retinal disease, specifically GUCY2D Leber Congenital Amaurosis (LCA1).

Dr. Shannon E. Boye

Recent Lab News

Dr. Calabro Receives NIH Pediatric Loan Repayment…

Congratulations to Dr. Kaitlyn Calabro for her receipt of the competitive NIH Pediatric Loan Repayment Program award! Kait’s award will relieve the…

Kait Calabro

Durham biotech company working on a therapy for…

Shannon Boye, a scientist at the University of Florida, is the co-founder of a new gene-therapy startup in Durham called Atsena Therapeutics. The…

Shannon Boye

Dr. Boye to Give Opening Presentation at VISIONS…

Participants of Virtual VISIONS 2020 are invited to join live for the opening presentation, “Mission Possible! What’s Next for Gene Therapy…

Logo for Foundation Fighting Blindness